Effect of Metformin on Survival Outcomes in Diabetic Patients With Triple Receptor-Negative Breast Cancer

Cited by (177)

Items 101–177 of 177

1. Metformin induces a senescence-associated gene signature in breast cancer cells
   Williams, Christopher C., Singleton, Brittany A., Llopis, Shawn D., Skripnikova, Elena V. · 2013 · Journal of Health Care for the Poor and Underserved
2. An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes
   Ling Bai, Howard Hua Yang, Ying Hu, Anjali Shukla, Ngoc‐Han Ha, Anthony Doran, Farhoud Faraji, Natalie E. Goldberger, Maxwell P. Lee, Thomas Keane et al. · 2016 · PLoS Genetics
3. Treatment and outcomes in diabetic breast cancer patients
   Heather Taffet Gold, Nour Makarem, Joey Nicholson, Niyati Parekh · 2014 · Breast Cancer Research and Treatment
4. Metformin to Treat Cancer
   Samy Suissa · 2017 · Epidemiology
5. Metformin treatment response is dependent on glucose growth conditions and metabolic phenotype in colorectal cancer cells
   Abdelnour H. Alhourani, Tia Tidwell, Ansooya A. Bokil, Gro Vatne Røsland, Karl Johan Tronstad, Kjetil Søreide, Hanne Røland Hagland · 2021 · Scientific Reports
6. The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials
   Jianhong Liu, Ming Zhang, Dan Deng, Xiao Ming Zhu · 2023 · Archives of Pharmacal Research
7. Repurposing of drugs for triple negative breast cancer: an overview
   Andrea Spini, Sandra Donnini, Pan Pantziarka, Sergio Crispino, Marina Ziche · 2020 · ecancermedicalscience
8. Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women
   Jin‐Liern Hong, Michele Jönsson Funk, John B. Buse, Louise M. Henderson, Jennifer Leigh Lund, Virginia Pate, Til Stürmer‎ · 2017 · Epidemiology
9. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
   Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne M. Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola‐Vuorinen et al. · 2020 · Acta Oncologica
10. Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients – a retrospective study of clinical and tumor characteristics
    Nikola Bešič, Nika Šatej, Ivica Ratoša, Andreja Gojkovic Horvat, Tanja Marinko, Barbara Gazić, Rok Petrič · 2014 · BMC Cancer
11. The Effect of Metformin on Mortality Among Diabetic Cancer Patients: A Systematic Review and Meta-analysis
    Xun Cao, Yaopan Wu, Jing Wang, Kui‐Yuan Liu, Xin Wang · 2017 · JNCI Cancer Spectrum
12. Impact of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer
    Wayne Rashaan Lawrence, Akiko S. Hosler, Margaret A. Gates, Matthew C. Leinung, Xiuling Zhang, Maria J. Schymura, Francis P. Boscoe · 2020 · Cancer Epidemiology
13. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies
    Jing Yang, Hang Yang, Ling Cao, Yuzhen Yin, Ying Shen, Wei Zhu · 2022 · Medicine
14. Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis
    Aaron P. Thrift · 2015 · Clinical Gastroenterology and Hepatology
15. Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
    Cui-Song Luo, Yun Lin, Weiping Zhou, Jun Shi · 2019 · European Journal of Gastroenterology & Hepatology
16. Physical Needs of Long-term Cancer Patients
    Paolo Tralongo, Maria Giovanna Pescarenico, Antonella Surbone, Sebastiano Bordonaro, Massimiliano Berretta, Annamaria Di Mari · 2017 · Anticancer Research
17. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
    Salvador Harguindey, Khalid Omer Alfarouk, Julian David Polo Orozco, Kévin Hardonnière, Daniel Stanciu, Stefano Fais, Jesús Devesa · 2020 · International Journal of Molecular Sciences
18. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus
    Tianli Hui, Chao Shang, Yang Liu, Meiqi Wang, Ruoyang Li, Zhenchuan Song · 2021 · Scientific Reports
19. When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?
    Noriko N. Yokoyama, Andria P. Denmon, Edward Uchio, Mark L. Jordan, Dan Mercola, Xiaolin Zi · 2015 · Current Pharmacology Reports
20. Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians
    Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla Maria La Verde · 2023 · International Journal of Molecular Sciences
21. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
    Lukas Löfling, Nathalie C. Støer, Bettina Kulle, Giske Ursin, Edoardo Botteri · 2023 · Breast Cancer Research
22. Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
    Kaitlyn Kennard, Meghan E. Buckley, Lina M. Sizer, Sharon L. Larson, William B. Carter, Thomas G. Frazier, Ned Z. Carp · 2021 · Breast Cancer Research and Treatment
23. Perspectives of metformin use in endometrial cancer and other gynaecological malignancies
    Bartłomiej Barczyński, Karolina Frąszczak, Jan Kotarski · 2021 · Journal of drug targeting
24. Comorbidities, Clinical Features, and Prognostic Implications of Cancer Patients with Cerebrovascular Disease
    Bernardo Cacho Díaz, Nydia A. Lorenzana-Mendoza, Héctor Spínola-Maroño, Gervith Reyes Soto, Carlos Gerardo Cantú-Brito · 2017 · Journal of Stroke and Cerebrovascular Diseases
25. Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors
    Avonne E. Connor, Kala Visvanathan, Stephanie D. Boone, Nader Rifai, Kathy B. Baumgartner, Richard Baumgartner · 2018 · npj Breast Cancer
26. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
    Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne M. Ahtikoski, Ulla Puistola, Esa Läärä, Peeter Karihtala et al. · 2021 · Scientific Reports
27. Factors influencing the anticancer effects of metformin on breast cancer outcomes: a systematic review and meta-analysis
    Hadeer Ehab Barakat, Raghda R. S. Hussein, Ahmed Abdullah Elberry, Mamdouh Ahmed Zaki, Mamdouh Elsherbiny Ramadan · 2022 · Expert Review of Anticancer Therapy
28. Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer
    Nalo M. Hamilton, Diana C. Márquez‐Garbán, Vei H. Mah, Yahya Elshimali, David A. Elashoff, Edward B. Garon, Jaydutt V. Vadgama, Richard J. Pietras · 2015 · Critical Reviews™ in Oncogenesis
29. In-vitro immune-modulation of triple-negative breast cancer through targeting miR-30a-5p/MALAT1 axis using nano-PDT combinational approach
    Asmaa Ramzy, Mohammad Abdel‐Halim, Tamer Manie, Noha Mousaad Elemam, Samar Mansour, Rana Ahmed Youness, Aya Ahmed Sebak · 2025 · Translational Oncology
30. Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
    Salvador Harguindey, Khalid Omer Alfarouk, Julian David Polo Orozco, Stefano Fais, Jesús Devesa · 2020 · International Journal of Molecular Sciences
31. Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics
    Amiya Das, Pallavi Agarwal, Gaurav Kumar Jain, Geeta Aggarwal, Viney Lather, Deepti Pandita · 2021 · Anti-Cancer Agents in Medicinal Chemistry
32. Quels bénéfices antitumoraux attendre de la metformine ?
    Emmanuel Beck, André Jacques Scheen · 2013 · Annales d Endocrinologie
33. Metformin in selected malignancies in women
    Anna Markowska, Joanna Stanisławiak‐Rudowicz, Tomasz Kasprzak, Janina Markowska, Monika Szarszewska · 2021 · Ginekologia Polska
34. The anti-proliferative role of metformin in non-diabetic female patients with breast cancer: systematic review and meta-analysis of randomized control trials
    Hanan Ali Abdullah Alghalib, AFNAN DHIAFALLAH ALOTAIBI, Bader Al Tulaihi, Shatha Ali A. AlGhaleb · 2020 · Clinical Diabetology
35. Metformin-induced downregulation of c-Met is a determinant of sensitivity in MDA-MB-468 breast cancer cells
    Dana M A Gant, Amanda B. Parris, Xiaohe Yang · 2022 · Biochemical and Biophysical Research Communications
36. Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity
    Şahika Cıngır Köker, Banu Yalçin, İrem Doğan · 2022 · Molecular Biology Reports
37. Obesity and Diabetes
    Alexandra Kautzky‐Willer, Rosa Lemmens‐Gruber · 2012 · Handbook of experimental pharmacology
38. The Effect of Metformin on Survival Outcomes of Non-Metastatic Breast Cancer Patients with Type 2 Diabetes
    Bita Behrouzi, Mohammad Zokaasadi, Mohammad Ali Mohagheghi, Amir Emami, Sanambar Sadighi · 2021 · Asian Pacific Journal of Cancer Prevention
39. Metformin: Midlife maturity, maiden charm
    Sanjay Kalra, Puneet Dhamija, AshokK Das · 2012 · Indian Journal of Endocrinology and Metabolism
40. Bridging the gap: exploring the causal relationship between metformin and tumors
    Zexin Zhang, Wenfeng Wu, Zexia Wu, Yihan He, Xuesong Chang, shenyuan deng, Rui Zhou, Yadong Chen, Haibo Zhang · 2024 · Frontiers in Genetics
41. Epidemiology of Cardio-Oncology
    Carrie Geisberg Lenneman, Gretchen Genevieve Kimmick, Douglas B. Sawyer · 2017 · Springer eBooks
42. Preventive and (Neo)Adjuvant Therapeutic Effects of Metformin on Cancer
    Yile Jiao, Xiaochen Wang, Zhijun Luo · 2020 · IntechOpen eBooks
43. MDA-MB-231 breast cancer cells adapted to anchorage-independent growth reveal senescent-like phenotype and persistent downregulation of PD-L1 expression
    Tadeja Snedec, Jernej Repas, Darin Lah, Špela Zemljič Jokhadar, Mojca Pavlin · 2025 · Frontiers in Oncology
44. Additive Anticancer and Antioxidant Effects of Metformin and Luteolin in Breast and Colorectal Cancer Cell Lines
    Katarzyna Gębczak, Łucja Cwynar-Zając, Monika Sapeta-Nowińska, Ewa Barg · 2025 · Pharmaceuticals
45. Obesity and Insulin Resistance in Breast Cancer: Are Clinical Trials Needed?
    Pamela Jean Goodwin · 2012 · Breast Diseases A Year Book Quarterly
46. Novel Therapies Metformin: The sweet link between tumor genetics and metabolism?
    Kristen L. Nowak, Harriet Eldredge-Hindy, CE Champ · 2014
47. Influence of metformin therapy on breast cancer incidence and prognosis
    Ðordje Popovic, LAZAR S. POPOVIC, Edita Stokić, Dragana Tomić-Naglić, Milena Mitrović, Branka Kovačev-Zavišić · 2012 · Archive of oncology
48. Anticancer role of antidiabetic drug Metformin in ovarian cancer cells
    Seema V. Patel, Neeta Singh, Lalit Kumar · 2016 · International Journal of Cancer Therapy and Oncology
49. Metformin in breast cancer treatment
    M. A. Osipov, T. U. Semiglazova, Петр Владимирович Криворотько, V. V. Klimenko, Vladimir Kostorov, В. В. Семиглазов, Evgenia V. Tsyrlina, Irina G. Popovich, V. N. Anisimov, Владимир Федорович Семиглазов et al. · 2017 · Malignant tumours
50. Repurposing of a muscle relaxant drug thiocolchicoside as an anticancer agent
    Shreya Medhi, Simran Narvekar, Amrita Srivastav · 2021 · MGM Journal of Medical Sciences
51. Combination of oxabicycloheptene sulfonate (OBHS) and antidiabetic drugs synergistically inhibits proliferation in human breast cancer cells
    Kexin Wang, Jian Huang · 2025 · ONCOLOGIE
52. Adiponectin-Based Therapeutics for Cancer Treatment
    Dahui Li, Handi Cao, Jie Chen, Ming Rong Liu, Yu Wang · 2017 · BENTHAM SCIENCE PUBLISHERS eBooks
53. Hubungan Penyakit Diabetes Melitus dan Penggunaan Antidiabetes terhadap Rekurensi pada Pasien Kanker Payudara
    Fitri Wulandari, Kartika Widayati, Fita Rahmawati · 2019 · JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
54. Pharmacological interventions part IV: Metabolic modifiers
    Tomas Koltai, Stephan J. Reshkin, Salvador Harguindey · 2020 · Elsevier eBooks
55. Metformin Resistant MDA-MB-468 Cells Exhibit EMT-like Phenotype and Increased Migration Capacity
    Şahika Cıngır Köker, Banu Yalçin, İrem Doğan · 2021 · Research Square
56. Optimierung der Therapie des metastasierten Mammakarzinoms unter besonderer Berücksichtigung des Pi3K/Akt/mTOR-Signaltransduktionswegs
    Jan Eucker · 2013 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
57. Metformin Impacts the Prognosis of Cancer Patients with Type 2 Diabetes
    Mihaela D. Aldea, Lucian Craciun, Carmen Bianca Crivii · 2014 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
58. Hypertension and diabetes treatments and risk of adverse outcomes among breast cancer patients
    Lu Chen · 2016 · ResearchWorks at the University of Washington (University of Washington)
59. Effects of Metformin on Breast Cancer Risk and Mortality in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
    Pusoon Chun · 2015 · Korean Journal of Clinical Pharmacy
60. The Association between Metformin Therapy and Mortality Following Breast Cancer: A Population-based Study
    Iliana Carolina Lega · 2013 · TSpace (University of Toronto)
61. The Prevention and Control of Cancer by Metformin in Patients with Type 2 Diabetes: A Systematic Mapping Review
    Albania Mitchell, Michelle Price, Gabriela C. Cipriano · 2021 · medRxiv
62. Breast Cancer Risk after Metformin Initiation in Older Women: the Role of Study Design, Potential Confounding by Body Mass Index, and Differential Detection
    Jin‐Liern Hong · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
63. Epigenetic regulation of resistance to treatments in triple negative and HER2+ breast cancer: miRNAs involved
    Paula Cabello Navarro · 2020
64. Metformin May Block the Way Breast Cancer Metastasis: A Meta-analysis and Mechanism Review
    Ming Wei Yang, Yueyuan Wang, Zhihao Zhang, Jingyu Peng, Xiao Xie, Xue Wei · 2020 · Research Square
65. Current World Literature
    2013 · Current Opinion in Obstetrics & Gynecology
66. Optimizing the treatment of oesophageal cancer
    Van De Voorde Lien · 2020
67. Metformin Resistant MDA-MB-468 Cells Exhibit EMT-like Phenotype and Increased Migration Capacity
    Şahika Cıngır Köker, Banu Yalçin, İrem Doğan · 2021 · Research Square
68. Molecular Heterogeneity in Primary and Metastatic Prostate Tumor Tissue
    Julie L. Batista · 2015 · Defense Technical Information Center (DTIC)
69. Effect of metformin on the prognosis of chemoradiotherapy cancer patients: a systematic review and meta-analysis of randomized controlled trials and cohort studies
    Da Wang, Penglai Zhao, Xiaohua Dong, Haizhong Ma, Miao Yu, Kehu Yang, Hui Cai · 2023 · Research Square
70. All-cause and cause-specific mortality among Medicaid-insured women with preexisting type 2 diabetes mellitus diagnosed with breast cancer : an epidemiological analysis of linked New York State Medicaid and cancer registry data
    Wayne Lawrence · 2020 · Scholars Archive - University at Albany (University at Albany, State University of New York)
71. Additional file 1 of Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
    Lukas Löfling, Nathalie C. Støer, Bettina Kulle, Giske Ursin, Edoardo Botteri · 2024 · Figshare
72. Additional file 1 of Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
    Suwei Dong, Yanbin, Xiao, Jianqiang, Wang, Xiang, Ma, Zhuohui Peng, Jianping, Kang, Yunqing Wang, Zhen Li · 2022 · Figshare
73. Additional file 2 of Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
    Suwei Dong, Yanbin, Xiao, Jianqiang, Wang, Xiang, Ma, Zhuohui Peng, Jianping Kang, Yunqing, Wang, Zhen Li · 2022 · Figshare
74. Teachers’ Professional Development Programs and Their Performance Rating
    Vanessa Jean Magdalera, Aida Selecios · 2026 · Psychology and Education A Multidisciplinary Journal
75. Impact of Metformin Use on Clinical and Pathological Outcomes in Breast Cancer Patients With Type 2 Diabetes
    Ensiyeh Bahadoran, Monirsadat Mirzadeh, Mohsen Jafari, Yazdan Zafari, Sahar Moghbelinejad · 2026 · Cancer Reports
76. BindingDB Entry 50018238: Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions.
    BindingDB · 2024 · UC San Diego
77. A Framework for the Multilevel Integration of Molecular, Clinical, and Population Data in the Context of Breast Cancer: Challenges and Considerations of Socioecological Conditions and Pharmacogenomics
    Matthew K. Breitenstein · 2015 · University of Minnesota Digital Conservancy (University of Minnesota)